IP Library Granted Patent US 11,511,022
Granted Patent B2
US 11,511,022 · App. 16/905,382 · Granted Nov 29, 2022

Stimulation of cartilage formation using reduced pressure treatment

Inventors: Marcus Christian Lessing (San Antonio, TX); Braden King-fung Leung (San Antonio, TX)
Assignee: KCI Licensing, Inc.
A61M1/0023A61L27/3817A61M1/0058A61M1/84A61M1/92A61M5/14A61M5/158A61L2300/434A61L2430/06A61L2430/14A61L2430/24A61M2210/02A61M2210/0662
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,511,022
App. No.
16/905,382
Granted
Nov 29, 2022
Kind
B2
Abstract

System and methods for stimulating cartilage formation at a first tissue site through a second tissue site is presented. The system includes a fluid source for supplying a therapeutic solution, a reduced pressure source for supplying reduced pressure, a fluid delivery manifold for deploying adjacent the first tissue site, and a vacuum manifold for deploying within the second tissue site. The fluid delivery manifold extends between a proximal end fluidly coupled to the fluid supply and a distal end having at least one aperture for delivering the therapeutic solution to the defect adjacent the articulating surface of the first tissue site. The vacuum manifold extends between a proximal end fluidly coupled to the reduced pressure source and a distal end having at least one aperture for delivering the reduced pressure to the first tissue site adjacent the opposing surface of the first tissue site.

Claims (31)

1. A method for treating a defect in cartilage comprising:

positioning a vacuum manifold within a subchondral bone;

positioning a fluid delivery manifold within an intra-articular space adjacent a surface of the subchondral bone;

delivering a therapeutic solution to the defect through the fluid delivery manifold; and

applying reduced pressure to the vacuum manifold to draw the therapeutic solution from the fluid delivery manifold through the defect.

2. The method of claim 1 , further comprising a step of creating a hole in the subchondral bone for positioning the vacuum manifold within the subchondral bone.

3. The method of claim 1 , wherein the therapeutic solution comprises a cell suspension.

4. The method of claim 1 , wherein the therapeutic solution comprises protease inhibitors.

5. The method of claim 1 , wherein the therapeutic solution comprises hyaluronic acid.

6. The method of claim 1 , wherein the therapeutic solution comprises bioactive factors.

7. The method of claim 1 , wherein the therapeutic solution comprises chondrocytes.

8. The method of claim 1 , wherein the therapeutic solution comprises bone marrow stromal cells.

9. The method of claim 1 , wherein the therapeutic solution comprises stem cells.

10. The method of claim 1 , wherein the therapeutic solution comprises collagen.

11. The method of claim 1 , wherein the vacuum manifold comprises at least one aperture, wherein the at least one aperture is positioned within the subchondral bone.

12. The method of claim 11 , wherein the at least one aperture is configured to direct the therapeutic solution toward the defect.

13. The method of claim 12 , wherein the at least one aperture is arranged in a single row facing a single direction.

14. The method of claim 12 , wherein the at least one aperture is staggered around a circumference of the vacuum manifold.

15. The method of claim 1 , wherein the fluid delivery manifold comprises at least one aperture.

16. The method of claim 15 , wherein the at least one aperture comprises a row of fluid apertures facing a single direction.

17. The method of claim 15 , wherein the at least one aperture comprises a plurality of staggered apertures.

18. The method of claim 15 , wherein the at least one aperture comprises a plurality of fluid apertures aligned around a circumference of the fluid delivery manifold.

19. A method for treating a cartilage defect comprising:

positioning a fluid delivery manifold on a first face of a cartilage defect;

positioning a vacuum manifold on a second face of the cartilage defect and within a subchondral bone supporting the cartilage defect;

delivering a therapeutic solution to the cartilage defect through the fluid delivery manifold; and

applying reduced pressure to the vacuum manifold to draw the therapeutic solution from the fluid delivery manifold through the cartilage defect.

20. The method of claim 19 , wherein the first face of the cartilage defect is substantially opposite the second face of the cartilage defect.

21. The method of claim 19 , wherein the fluid delivery manifold is positioned substantially parallel to the vacuum manifold.

22. The method of claim 19 , wherein the fluid delivery manifold is positioned at an angle relative to the vacuum manifold.

23. The method of claim 19 , wherein applying reduced pressure causes the therapeutic solution to flow from the first face of the cartilage defect, through an interior of the cartilage defect and at least a portion of the subchondral bone, and out the second face of the cartilage defect to the vacuum manifold.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066444/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064718/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2020
From: LESSING, MARCUS CHRISTIAN; LEUNG, BRADEN K
To: KCI LICENSING, INC.
Reel/Frame 052986/0386 →